Altos Labs

Altos Labs is a well-funded, private biotechnology company with a mission to restore cell health and resilience through cellular rejuvenation, aiming to reverse a broad spectrum of diseases. Founded on the groundbreaking work of scientists like Shinya Yamanaka and Juan Carlos Izpisua Belmonte, the company has established a global presence with institutes in key biotech hubs. Its strategy combines deep biological research, a powerful computational ecosystem, and a hybrid academic-industry model to accelerate the discovery and development of novel therapeutics.

A cellular rejuvenation programming platform based on partial reprogramming science (Yamanaka factors), aiming to transiently reset cellular age and restore health and resilience to treat and reverse a wide range of diseases.

Competes with other reprogramming biotechs (Life Biosciences, Rejuvenate Bio), senolytic companies (Unity), and well-funded research entities (Calico). Differentiation stems from unparalleled funding, direct lineage to foundational science, a hybrid research model, and deep computational integration.